| Asset | 31 Jul 2026 | 30 Jun 2026 | 31 May 2026 | 30 Apr 2026 | 31 Mar 2026 | 28 Feb 2026 |
|---|---|---|---|---|---|---|
| Equity | 99.93% | 100.02% | 100.24% | 100.04% | 100.01% | 100.07% |
| Debt | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Others (incl. cash) | 0.07% | -0.02% | -0.24% | -0.04% | -0.01% | -0.07% |
| Commodities | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Real Estate | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Instrument | Sector | No. of Shares | Value (Rs. Cr) | Weight | Change |
|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | Healthcare | 15,873 | 3.16 | 13.35% | 0.45%↑ |
| Divis Laboratories Ltd. | Healthcare | 1,873 | 1.51 | 6.38% | 1.01%↑ |
| Apollo Hospitals Enterprise Ltd. | Healthcare | 1,501 | 1.34 | 5.68% | -0.01%↓ |
| Cipla Ltd. | Healthcare | 8,313 | 1.22 | 5.18% | -0.13%↓ |
| Max Healthcare Institute Ltd. | Healthcare | 10,875 | 1.19 | 5.05% | -0.31%↓ |
| Torrent Pharmaceuticals Ltd. | Healthcare | 2,101 | 1.07 | 4.53% | 1.52%↑ |
| Dr. Reddys Laboratories Ltd. | Healthcare | 8,957 | 1.03 | 4.35% | -0.95%↓ |
| Laurus Labs Ltd. | Healthcare | 5,635 | 1.02 | 4.33% | 0.60%↑ |
| Lupin Ltd. | Healthcare | 3,563 | 0.86 | 3.64% | -0.12%↓ |
| Fortis Healthcare Ltd. | Healthcare | 7,659 | 0.72 | 3.06% | -0.14%↓ |
| Aurobindo Pharma Ltd. | Healthcare | 4,099 | 0.65 | 2.74% | -0.08%↓ |
| Alkem Laboratories Ltd. | Healthcare | 861 | 0.5 | 2.09% | 0.00% |
| Glenmark Pharmaceuticals Ltd. | Healthcare | 2,199 | 0.49 | 2.08% | -0.03%↓ |
| Biocon Ltd. | Healthcare | 10,485 | 0.45 | 1.89% | -0.02%↓ |
| Zydus Lifesciences Ltd. | Healthcare | 3,698 | 0.42 | 1.76% | -0.03%↓ |
| Mankind Pharma Ltd. | Healthcare | 1,639 | 0.4 | 1.71% | -0.11%↓ |
| Ipca Laboratories Ltd. | Healthcare | 2,051 | 0.36 | 1.51% | -0.01%↓ |
| Aster DM Quality Care Ltd. | Healthcare | 3,885 | 0.32 | 1.35% | 0.02%↑ |
| Krishna Institute of Medical Sciences Ltd | Healthcare | 3,647 | 0.29 | 1.24% | -0.06%↓ |
| Gland Pharma Ltd. | Healthcare | 1,163 | 0.29 | 1.23% | -0.03%↓ |
| Sector | 31 Jul 2026 | 30 Jun 2026 | 31 May 2026 | 30 Apr 2026 | 31 Mar 2026 | 28 Feb 2026 |
|---|---|---|---|---|---|---|
| Healthcare | 99.52% | 99.58% | 99.78% | 99.52% | 99.55% | 99.57% |
| Services | 0.22% | 0.24% | 0.24% | 0.29% | 0.25% | 0.30% |
| Chemicals | 0.19% | 0.20% | 0.22% | 0.23% | 0.21% | 0.20% |
30.0 / 100
Weighted average Value score is 30.0. This indicates that portfolio is relatively reasonably valued using composite of value measures.
69.2 / 100
Weighted average Price Momentum score is 69.2. This indicates that portfolio has average momentum using composite of momentum measures.
83.3 / 100
Weighted average Quality score is 83.3. This indicates that portfolio has high quality using composite of quality measures.
70.1 / 100
Weighted average QVM score is 70.1. This indicates that portfolio has average QVM score and hence a neutral stance is warranted.
